» Articles » PMID: 20306269

Multi-organ Distribution of Phosphorylated Alpha-synuclein Histopathology in Subjects with Lewy Body Disorders

Overview
Specialty Neurology
Date 2010 Mar 23
PMID 20306269
Citations 406
Authors
Affiliations
Soon will be listed here.
Abstract

A sensitive immunohistochemical method for phosphorylated alpha-synuclein was used to stain sets of sections of spinal cord and tissue from 41 different sites in the bodies of 92 subjects, including 23 normal elderly, 7 with incidental Lewy body disease (ILBD), 17 with Parkinson's disease (PD), 9 with dementia with Lewy bodies (DLB), 19 with Alzheimer's disease with Lewy bodies (ADLB) and 17 with Alzheimer's disease with no Lewy bodies (ADNLB). The relative densities and frequencies of occurrence of phosphorylated alpha-synuclein histopathology (PASH) were tabulated and correlated with diagnostic category. The greatest densities and frequencies of PASH occurred in the spinal cord, followed by the paraspinal sympathetic ganglia, the vagus nerve, the gastrointestinal tract and endocrine organs. The frequency of PASH within other organs and tissue types was much lower. Spinal cord and peripheral PASH was most common in subjects with PD and DLB, where it appears likely that it is universally widespread. Subjects with ILBD had lesser densities of PASH within all regions, but had frequent involvement of the spinal cord and paraspinal sympathetic ganglia, with less-frequent involvement of end-organs. Subjects with ADLB had infrequent involvement of the spinal cord and paraspinal sympathetic ganglia with rare involvement of end-organs. Within the gastrointestinal tract, there was a rostrocaudal gradient of decreasing PASH frequency and density, with the lower esophagus and submandibular gland having the greatest involvement and the colon and rectum the lowest.

Citing Articles

Sympathetic and parasympathetic subtypes of body-first Lewy body disease observed in postmortem tissue from prediagnostic individuals.

Andersen K, Krishnamurthy A, Just M, Van Den Berge N, Skjaerbaek C, Horsager J Nat Neurosci. 2025; .

PMID: 40082617 DOI: 10.1038/s41593-025-01910-9.


Assessment of gastrointestinal function and enteric nervous system changes over time in the A53T mouse model of Parkinson's disease.

Han M, Di Natale M, Lei E, Furness J, Finkelstein D, Hao M Acta Neuropathol Commun. 2025; 13(1):58.

PMID: 40075409 PMC: 11899089. DOI: 10.1186/s40478-025-01956-7.


The Inflammatory Mechanism of Parkinson's Disease: Gut Microbiota Metabolites Affect the Development of the Disease Through the Gut-Brain Axis.

Gao A, Lv J, Su Y Brain Sci. 2025; 15(2).

PMID: 40002492 PMC: 11853208. DOI: 10.3390/brainsci15020159.


Microbial Trojan Horses: Virulence Factors as Key Players in Neurodegenerative Diseases.

Grahl M, Hohl K, Smaniotto T, Carlini C Molecules. 2025; 30(3).

PMID: 39942791 PMC: 11820544. DOI: 10.3390/molecules30030687.


Lewy body diseases and the gut.

Sampson T, Tansey M, West A, Liddle R Mol Neurodegener. 2025; 20(1):14.

PMID: 39885558 PMC: 11783828. DOI: 10.1186/s13024-025-00804-5.


References
1.
Fujiwara H, Hasegawa M, Dohmae N, Kawashima A, Masliah E, Goldberg M . alpha-Synuclein is phosphorylated in synucleinopathy lesions. Nat Cell Biol. 2002; 4(2):160-4. DOI: 10.1038/ncb748. View

2.
. Consensus recommendations for the postmortem diagnosis of Alzheimer's disease. The National Institute on Aging, and Reagan Institute Working Group on Diagnostic Criteria for the Neuropathological Assessment of Alzheimer's Disease. Neurobiol Aging. 1997; 18(4 Suppl):S1-2. View

3.
Proulx M, de Courval F, Wiseman M, Panisset M . Salivary production in Parkinson's disease. Mov Disord. 2004; 20(2):204-7. DOI: 10.1002/mds.20189. View

4.
Braak H, Braak E . Demonstration of amyloid deposits and neurofibrillary changes in whole brain sections. Brain Pathol. 1991; 1(3):213-6. DOI: 10.1111/j.1750-3639.1991.tb00661.x. View

5.
Sica R, Sanz O . An electrophysiological study of the functional changes in the spinal motoneurones in Parkinson's disease. Electromyogr Clin Neurophysiol. 1976; 16(5):409-17. View